PFE
HEALTHCAREPfizer Inc
$26.53+0.08 (+0.30%)PRE
Live · NYSE · May 8, Close
AI Insight
What's Moving PFE Today?
No stock-specific AI insight has been generated for PFE yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$20.87$28.75
$26.53
Fundamentals
Market Cap$151.2B
P/E Ratio20.3
EPS$1.31
Dividend Yield0.07%
Dividend / Share$1.72
ROE0.1%
Profit Margin0.1%
Debt / Equity—
Trading
Volume40.4M
Avg Volume (10D)—
Shares Outstanding5.70B
PFE News
59 articles- M&T Bank Corp Has $1.79 Million Holdings in Regency Centers Corporation $REGMarketBeat·May 9, 2026
- Crossmark Global Holdings Inc. Has $24.83 Million Stock Position in Merck & Co., Inc. $MRKMarketBeat·May 9, 2026
- Here is Why Pfizer (PFE) One of the Best High Volume Stocks to Invest InYahoo Finance·May 9, 2026
- 3 Healthcare Stocks Every Retiree Should ConsiderThe Motley Fool·May 8, 2026
- GLP-1 battle heats up between Eli Lilly and Novo NordiskYahoo Finance UK·May 8, 2026
- Giants of Cancer Care® announces the 14th annual class of inducteesYahoo Finance·May 8, 2026
- Gene Therapy Briefs: Regeneron Wins FDA Approval for First Neurosensory Gene TherapyGenetic Engineering and Biotechnology News·May 8, 2026
- Forget Eli Lilly: These 2 Stocks Have More UpsideMotley Fool·May 7, 2026
- Pfizer’s Next Lyme Shot: What a Fifth-Dose VLA15 Trial Signals for PFE InvestorsTipRanks·May 7, 2026
- Darzalex, Erleada & New Drugs Keep J&J's Oncology Engine Charged in Q1Yahoo Finance·May 7, 2026
- NVAX Q1 Earnings Beat, Stock Jumps 16% on Matrix-M Deal MomentumYahoo Finance·May 7, 2026
- Regeneron Pharmaceuticals, Inc. $REGN Shares Purchased by K.J. Harrison & Partners IncMarketBeat·May 7, 2026
- MBX Biosciences Announces Appointment of Mark Soued as Chief Commercial Officer and Inducement Grant AwardYahoo Finance·May 7, 2026
- Pfizer's 6.5% Dividend Yield Looked Too Good to Be True -- but Management Just Silenced the SkepticsMotley Fool·May 7, 2026
- How Pfizer’s Q1 Beat, Oncology Wins and Patent Deals At Pfizer (PFE) Has Changed Its Investment StoryYahoo Finance·May 7, 2026
- History Suggests These 3 Stocks Are Due for a Major ReboundThe Motley Fool·May 6, 2026
- Pfizer’s newer medicines carry more weight in Q1The Street·May 6, 2026
- Novavax Q1 Earnings Call HighlightsMarketbeat·May 6, 2026
- As AI Rewrites Drug Development, the Industry Gathers in Philadelphia to Work Out the RulesYahoo Finance·May 6, 2026
- Pfizer CEO Backs Trump's CDC Pick After Vaccine Policy UpheavalYahoo Finance·May 6, 2026
- 6 Pharma Dividend Stocks Yielding Up to 6.44% — and They’ve Survived Every Market Crash247 Wall St·May 6, 2026
- A Look At Pfizer (NYSE:PFE) Valuation After Q1 2026 Beat And Pipeline ProgressYahoo Finance·May 6, 2026
- Stock Market News for May 6, 2026Yahoo Finance·May 6, 2026
- Can Pfizer Stock Outrun A $17B Revenue Void?Trefis·May 6, 2026
- Eileen Cheigh Nakamura joins GAMCO Board of DirectorsYahoo Finance·May 6, 2026
- Pfizer Stock: Still Priced Like It's Dead MoneyThe Motley Fool·May 3, 2026
- Moderna's Legal Hit Steals Spotlight From Strong SalesBenzinga·May 1, 2026
- Pfizer Says Cancer Therapy Beats Standard Therapy In Late-Stage Blood Cancer StudyBenzinga·Apr 29, 2026
- Retatrutide Crosses the Surgical Threshold, but the Real Race Has Just StartedGlobeNewswire Inc.·Apr 29, 2026
- Dietary Supplements Market Driven by Health and Nutrition DemandGlobeNewswire Inc.·Apr 29, 2026
- Antibiotic Resistance Market to Grow at 5.4% CAGR Reaching USD 12.72 Billion by 2031, Driven by Rising Drug-Resistant Infections and Antimicrobial Innovation: Mordor IntelligenceGlobeNewswire Inc.·Apr 28, 2026
- Stock Market Today, April 27: Organon Shares Surge After Sun Pharma Agrees to Acquire Company in All Cash DealThe Motley Fool·Apr 27, 2026
- AI Disruption in Lung Cancer Therapeutics Set to Transform Treatment Paradigms as Billion-Dollar Investments Drive InnovationGlobeNewswire Inc.·Apr 27, 2026
- Peripheral T-Cell Lymphoma Market to Witness Significant Expansion at a CAGR of 7% During the Forecast Period (2026–2036) Amid Advancing Treatment Landscape | DelveInsightGlobeNewswire Inc.·Apr 27, 2026
- Relay Therapeutics Announces Clinical Data for Zovegalisib plus Atirmociclib Triplet Combination Supportive of Further Development in Frontline Metastatic Breast CancerGlobeNewswire Inc.·Apr 27, 2026
- Is This Tech Giant the Next Potential Winner in the GLP-1 Weight Loss Boom?The Motley Fool·Apr 25, 2026
- TACO Trade Joke No More? Trump's Art Of The Deal' Powers S&P 500's Steepest Highs And LowsBenzinga·Apr 24, 2026
Price Data
Open$26.56
Previous Close$26.45
Day High$26.68
Day Low$26.21
52 Week High$28.75
52 Week Low$20.87
52-Week Range
$20.87$28.75
$26.53
Fundamentals
Market Cap$151.2B
P/E Ratio20.3
EPS$1.31
Dividend Yield0.07%
Dividend / Share$1.72
ROE0.1%
Profit Margin0.1%
Debt / Equity—
Trading
Volume40.4M
Avg Volume (10D)—
Shares Outstanding5.70B
About Pfizer Inc
Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered on 42nd Street in Manhattan, New York City. The name of the company commemorates its co-founder, Charles Pfizer (1824-1906). Pfizer develops and produces medicines and vaccines for immunology, oncology, cardiology, endocrinology, and neurology. The company has several blockbuster drugs or products that each generate more than 1 billion USD in annual revenues.
HEALTHCAREDRUG MANUFACTURERS - GENERAL
Company Details
Security TypeStock
ExchangeNYSE
CurrencyUSD
Round Lot—
SICDRUG MANUFACTURERS - GENERAL
CIK—
Composite FIGI—
Share Class FIGI—